SVG Ventures | THRIVE

SVG Ventures | THRIVE is a global venture and innovation firm headquartered in Silicon Valley, dedicated to advancing the future of food and agriculture through innovation. The firm accelerates, invests, and collaborates with entrepreneurs, investors, and Fortune 500 corporations to address the most pressing challenges in the agri-food sector. With a community of over 12,000 startups from more than 100 countries, SVG Ventures | THRIVE offers unparalleled access for entrepreneurs to scale globally. The firm's investment strategy focuses on early-stage technology companies reimagining industry sectors such as AgriFood, Climate, FinTech, Life Sciences, and Nutrition. By combining deep technology knowledge with decades of strategic and operational expertise, SVG Ventures | THRIVE aims to unlock undiscovered value in product development, next-generation growing practices, optimized supply chains, and asset management. The firm operates on a purpose-driven approach, supporting innovation that makes a difference for better business, better food, and better climate. Through its THRIVE platform, SVG Ventures | THRIVE delivers more than capital, offering deal flow, venture development, global partnerships, and sector expertise that directly benefit its portfolio companies and innovation partners. The platform engages with a diverse ecosystem, including farmers, startups, scale-ups, corporates, governments, investors, research institutions, and media, to create value across multiple layers based on deep ecosystem understanding and know-how. This comprehensive approach enables the firm to drive outcomes and long-term value, fostering an entrepreneurial mindset and a sense of ownership in its work with founders and partners.

Innovative solutions addressing challenges in the agri-food sector, Scalable business models with global potential, Alignment with sustainability and climate resilience goals, Strong founding teams with a clear vision and execution capability, Technologies leveraging AI, machine learning, and biotechnology